Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Geriatric Cancer Patients”

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00989352
What this trial is testing

Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-Lymphoma

Who this might be right for
Primary Non Hodgkin Lymphoma of the Central Nervous System
University Hospital Freiburg 56
Testing effectiveness (Phase 2)Study completedNCT01826214
What this trial is testing

Study of Efficacy and Safety of LDE225 in Adult Patients With Relapsed/Refractory Acute Leukemia

Who this might be right for
Acute Leukemias
Novartis Pharmaceuticals 70
Large-scale testing (Phase 3)Not Yet RecruitingNCT07407660
What this trial is testing

Shortened Venetoclax Duration Based on Day 14 BM Blasts Versus Standard Therapy in Elderly or Frail Patients With AML Patients Treated With Azacitidine Plus Venetoclax

Who this might be right for
Acute Myeloid Leukemia
Peking University People's Hospital 250
Testing effectiveness (Phase 2)UnknownNCT04824924
What this trial is testing

Venetoclax in Combination With Low-dose HHT, G-CSF, and AZA as First-line Treatment for Newly Diagnosed Elderly AML Patients Unfit for Intensive Chemotherapy

Who this might be right for
Leukemia, Myeloid, Acute
Shanghai Jiao Tong University School of Medicine 100
Not applicableUnknownNCT02175823
What this trial is testing

Health Status Evaluation for Cancer Survivors by Non-intrusive Sensing System

Who this might be right for
Cancer
National Taiwan University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00330746
What this trial is testing

CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer

Who this might be right for
Advanced Non-Small Cell Lung Cancer
National Cancer Institute, Naples 100
Testing effectiveness (Phase 2)UnknownNCT04622579
What this trial is testing

Lenalidomide Combined With Rituximab as Front-line Therapy for DLBCL Patients Aged Over 80 Years

Who this might be right for
Diffuse Large B Cell LymphomaAge Over 80 Years
Guangdong Provincial People's Hospital 20
Testing effectiveness (Phase 2)WithdrawnNCT04262869
What this trial is testing

Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8+2 more
Emory University
Not applicableUnknownNCT04208854
What this trial is testing

Observational Study With Metronomic Oral Vinorelbine in Elderly Patients With Locally Advanced / Metastatic Non-small-cell Lung Cancer (NSCLC)

Who this might be right for
Locally Advanced/ Metastatic NSCLC
International Group of Endovascular Oncology 40
Not applicableNot Yet RecruitingNCT07671586
What this trial is testing

Enhancing Patient Experience in Geriatric Oncology

Who this might be right for
ConfortOlder Adults With Cancer
Hospital Sirio-Libanes 264
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07398560
What this trial is testing

Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study

Who this might be right for
Small Cell Lung Cancer
The Third Affiliated Hospital of Harbin Medical University 47
Early research (Phase 1)Ended earlyNCT01642017
What this trial is testing

Phase I Clinical and Pharmacokinetic Study of Pazopanib in a Population of Frail Elderly Patients According SIOG Criteria

Who this might be right for
Metastatic Cancer (Different Solid Tumour Types)
Institut Claudius Regaud 18
Large-scale testing (Phase 3)Study completedNCT00278408
What this trial is testing

Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
German High-Grade Non-Hodgkin's Lymphoma Study Group 700
Not applicableStudy completedNCT02501174
What this trial is testing

Study of Elderly Patients With Cancer and Seen in Consultation of Geriatric Oncology in the Nord Pas-de-Calais (CONSOG).

Who this might be right for
Cancer
Centre Oscar Lambret 2,914
Testing effectiveness (Phase 2)Ended earlyNCT01522612
What this trial is testing

Colorectal Cancer (CRC) Cetuximab Elderly Frail

Who this might be right for
Colorectal Cancer Metastatic
European Organisation for Research and Treatment of Cancer - EORTC 5
Large-scale testing (Phase 3)Study completedNCT00976456
What this trial is testing

Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
PD Dr. med. Wolfgang Schuette 271
Testing effectiveness (Phase 2)Study completedNCT00256711
What this trial is testing

Phase II Iressa Versus Vinorelbine (INVITE)

Who this might be right for
Non-Small-Cell Lung Carcinoma
AstraZeneca 192
Testing effectiveness (Phase 2)Study completedNCT00600977
What this trial is testing

Liposomal Anthracyclin in the Treatment of Elderly ALL

Who this might be right for
Acute Lymphoblastic Leukemia
French Innovative Leukemia Organisation 60
Not applicableLooking for participantsNCT06891144
What this trial is testing

Epidemiological Study of a Prospective Cohort of Patients Aged 60 and Over Managed for Acute Myeloid Leukemia (AML) and Receiving Intensive Induction Therapy

Who this might be right for
AML, Adult
French Innovative Leukemia Organisation 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT05004064
What this trial is testing

Acalabrutinib and Rituximab in Previously Untreated Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
University College, London 48
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation